原代細胞市場：按來源（動物原代細胞、人類原代細胞）、按細胞類型（皮膚細胞、胃腸細胞、心臟細胞）、按最終用戶 - COVID-19、俄羅斯-烏克蘭衝突、高累積影響的累積- 全球2023-2030 年預測

全球原電池市場預計到2023年將達到14.326億美元，複合年成長率為12.08%，大幅成長，2030年將達到31.871億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球原電池市場至關重要。透過檢視業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使用戶能夠根據自己的具體需求做出資訊的決策。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.全球原電池市場規模及預測為何？

2.在預測期內，COVID-19 對全球原電池市場的阻礙因素和影響為何？

3.在預測期內，全球原電池市場需要投資哪些產品/細分市場/應用/領域？

4.你們在全球原電池市場的競爭策略是什麼？

5. 全球原代細胞市場的技術趨勢和法律規範是什麼？

6.全球原電池市場主要廠商的市佔率為何？

7. 哪些型態和策略措施被認為適合進入全球原代細胞市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

• 市場動態
  • 促進因素
    • 擴大藥物篩選和細胞檢測的接受度
    • 與其他現有方法相比，原代人類細胞的優勢
    • 對單株抗體和個人化醫療的日益關注
  • 抑制因素
    • 常見的細胞培養問題，例如污染
  • 機會
    • 擴大生物技術和生物製藥產業
    • 使用原代細胞進行醫學研究的進展
  • 任務
    • 細胞生物學研究領域的倫理問題
• 市場趨勢
• COVID-19 的累積影響
• 俄羅斯-烏克蘭衝突的累積影響
• 高通膨的累積效應
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 法律規範
• 客戶客製化

第6章 原代細胞市場（依來源）

• 動物原代細胞
• 人類原代細胞

第7章 原電池市場（以電池類型）

• 皮膚細胞
• 胃腸細胞
• 心臟細胞
• 造血細胞
• 肝細胞
  • 凍存肝細胞
  • 新鮮肝細胞
• 肺細胞
• 肌肉骨骼細胞
• 腎臟細胞

第8章 原電池市場：依最終用戶分類

• 生命科學公司
• 調查機構

第9章 美洲原代細胞市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第10章 亞太原電池市場

• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第11章歐洲、中東和非洲原電池市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第12章競爭形勢

• FPNV定位矩陣
• 市佔率分析：主要企業
• 競爭情境分析：主要企業

第13章上市公司名單

第14章附錄

• 討論指南
• 關於許可證和定價

The Global Primary Cells Market is forecasted to grow significantly, with a projected USD 1,432.60 million in 2023 at a CAGR of 12.08% and expected to reach a staggering USD 3,187.10 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Primary Cells Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Primary Cells Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Origin, market is studied across Animal Primary Cells and Human Primary Cells. The Animal Primary Cells is projected to witness significant market share during forecast period.

Based on Cell Type, market is studied across Dermatocytes, Gastrointestinal Cells, Heart Cells, Hematopoietic Cells, Hepatocytes, Lung Cells, Musculoskeletal Cells, and Renal Cells. The Hepatocytes is further studied across Cryopreserved Hepatocytes and Fresh Hepatocytes. The Renal Cells is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Life Science Companies and Research Institutes. The Research Institutes is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Primary Cells Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Primary Cells Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Primary Cells Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Primary Cells Market?

4. What is the competitive strategic window for opportunities in the Global Primary Cells Market?

5. What are the technology trends and regulatory frameworks in the Global Primary Cells Market?

6. What is the market share of the leading vendors in the Global Primary Cells Market?

7. What modes and strategic moves are considered suitable for entering the Global Primary Cells Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Primary Cells Market, by Origin, 2022 vs 2030
• 4.3. Primary Cells Market, by Cell Type, 2022 vs 2030
• 4.4. Primary Cells Market, by End-User, 2022 vs 2030
• 4.5. Primary Cells Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing acceptance in drug screening and cell based assays
    • 5.1.1.2. Advantages of primary human cells over other existing methods
    • 5.1.1.3. Growing focus on monoclonal antibodies and personalized medicine
  • 5.1.2. Restraints
    • 5.1.2.1. Common cell culture problems such as contamination
  • 5.1.3. Opportunities
    • 5.1.3.1. Expanding biotechnology and biopharmaceutical industries
    • 5.1.3.2. Advancements in biomedical research using primary cells
  • 5.1.4. Challenges
    • 5.1.4.1. Ethical issues in cell biology research field
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Primary Cells Market, by Origin

• 6.1. Introduction
• 6.2. Animal Primary Cells
• 6.3. Human Primary Cells

7. Primary Cells Market, by Cell Type

• 7.1. Introduction
• 7.2. Dermatocytes
• 7.3. Gastrointestinal Cells
• 7.4. Heart Cells
• 7.5. Hematopoietic Cells
• 7.6. Hepatocytes
  • 7.6.1. Cryopreserved Hepatocytes
  • 7.6.2. Fresh Hepatocytes
• 7.7. Lung Cells
• 7.8. Musculoskeletal Cells
• 7.9. Renal Cells

8. Primary Cells Market, by End-User

• 8.1. Introduction
• 8.2. Life Science Companies
• 8.3. Research Institutes

9. Americas Primary Cells Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Primary Cells Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Primary Cells Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. PRIMARY CELLS MARKET RESEARCH PROCESS
• FIGURE 2. PRIMARY CELLS MARKET SIZE, 2022 VS 2030
• FIGURE 3. PRIMARY CELLS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2022 VS 2030 (%)
• FIGURE 5. PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2022 VS 2030 (%)
• FIGURE 6. PRIMARY CELLS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
• FIGURE 7. PRIMARY CELLS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 8. PRIMARY CELLS MARKET DYNAMICS
• FIGURE 9. PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. PRIMARY CELLS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES PRIMARY CELLS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. PRIMARY CELLS MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 17. PRIMARY CELLS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. PRIMARY CELLS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. PRIMARY CELLS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 5. PRIMARY CELLS MARKET SIZE, BY ANIMAL PRIMARY CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. PRIMARY CELLS MARKET SIZE, BY HUMAN PRIMARY CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 8. PRIMARY CELLS MARKET SIZE, BY DERMATOCYTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. PRIMARY CELLS MARKET SIZE, BY GASTROINTESTINAL CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. PRIMARY CELLS MARKET SIZE, BY HEART CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. PRIMARY CELLS MARKET SIZE, BY HEMATOPOIETIC CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 13. PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. PRIMARY CELLS MARKET SIZE, BY CRYOPRESERVED HEPATOCYTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. PRIMARY CELLS MARKET SIZE, BY FRESH HEPATOCYTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. PRIMARY CELLS MARKET SIZE, BY LUNG CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. PRIMARY CELLS MARKET SIZE, BY MUSCULOSKELETAL CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. PRIMARY CELLS MARKET SIZE, BY RENAL CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 20. PRIMARY CELLS MARKET SIZE, BY LIFE SCIENCE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. PRIMARY CELLS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. CANADA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 36. CANADA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 37. CANADA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 38. CANADA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES PRIMARY CELLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. CHINA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 58. CHINA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 59. CHINA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 60. CHINA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. INDIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 62. INDIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 63. INDIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 64. INDIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. ITALY PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 131. ITALY PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 132. ITALY PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 133. ITALY PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. POLAND PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 147. POLAND PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 148. POLAND PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 149. POLAND PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. QATAR PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 151. QATAR PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 152. QATAR PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 153. QATAR PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 190. PRIMARY CELLS MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 191. PRIMARY CELLS MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 192. PRIMARY CELLS MARKET LICENSE & PRICING